<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34011812</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1882-0654</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Rinsho shinkeigaku = Clinical neurology</Title><ISOAbbreviation>Rinsho Shinkeigaku</ISOAbbreviation></Journal><ArticleTitle>[A proposal of a novel palliative care scale and analysis of suffering in amyotrophic lateral sclerosis].</ArticleTitle><Pagination><StartPage>361</StartPage><EndPage>367</EndPage><MedlinePgn>361-367</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5692/clinicalneurol.cn-001571</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We proposed a novel palliative care scale (Amyotrophic Lateral Sclerosis Palliative Care Scale: ALSPCS) for patients with ALS, and analyzed the suffering reported by patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-one patients participated in the study. The ALSPCS has 15 items to evaluate physical and psychological suffering; patients scored their subjective suffering on a scale of 0-5 for each item. This study analyzed 13 of 15 items.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean scores obtained from the patients were as follows: 'dyspnea', 2.5; 'pain', 2.4; 'restlessness', 2.4; 'thirst', 3.0; 'burning sensation', 2.0; 'choking', 2.0; 'nausea', 0.4; 'constipation', 1.5; 'insomnia', 2.5; 'anxiety', 3.5; 'loneliness', 2.4; 'irritation', 2.1; and 'communication difficulty', 2.3. Multiple correlation analysis using Spearman's rank correlation coefficient showed significant correlations of dyspnea with restlessness, thirst, burning sensation and anxiety; of restlessness with dyspnea, thirst, loneliness and irritation; and of anxiety with dyspnea, thirst and loneliness (P &lt; 0.0038 after Bonferroni's correction). In the principal component analysis, every item showed a positive loading value in the first principal component. Dyspnea, restlessness, thirst, anxiety, loneliness and irritation had loading values &gt;0.7; thus, these symptoms might be the main features in ALS patients. The total scores or each ALSPCS score showed no significant association with post-assessment survival period.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study, using ALSPCS, showed that the subjective suffering of ALS patients was variable and strongly correlated with each other. Appropriate and comprehensive assessment of physical and psychological affliction with ALSPCS could be potentially useful in verifying the effectiveness of palliative care for end-of-life stage ALS patients in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nursing Division, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onozaki</LastName><ForeName>Kanae</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nursing Division, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Tamami</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nursing Division, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morishima</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokuda</LastName><ForeName>Kota</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saotome</LastName><ForeName>Takako</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Arata</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Palliative Care Team, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropsychiatry, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Unit for Intractable Disease Nursing Care, Tokyo Metropolitan Institute of Medical Science.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Kazushi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital.</Affiliation></AffiliationInfo></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Rinsho Shinkeigaku</MedlineTA><NlmUniqueID>0417466</NlmUniqueID><ISSNLinking>0009-918X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011595" MajorTopicYN="N">Psychomotor Agitation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">dyspnea</Keyword><Keyword MajorTopicYN="N">end-of-life care</Keyword><Keyword MajorTopicYN="N">palliative care scale</Keyword><Keyword MajorTopicYN="N">suffering</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34011812</ArticleId><ArticleId IdType="doi">10.5692/clinicalneurol.cn-001571</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>